BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20949311)

  • 1. Biomagnetic methods: technologies applied to pharmaceutical research.
    Corá LA; Américo MF; Oliveira RB; Serra CH; Baffa O; Evangelista RC; Oliveira GF; Miranda JR
    Pharm Res; 2011 Mar; 28(3):438-55. PubMed ID: 20949311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AC biosusceptometry in the study of drug delivery.
    Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel device with 36 channels for imaging and signal acquisition of the gastrointestinal tract based on AC biosusceptometry.
    Paixao FC; Quini CC; Baffa O; Miranda JR
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():6457-60. PubMed ID: 21096717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location, location, location: gastrointestinal delivery site and its impact on absorption.
    Connor A
    Ther Deliv; 2012 May; 3(5):575-8. PubMed ID: 22834401
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical applications of AC biosusceptometry.
    Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR
    Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole.
    Ferrari PC; dos Santos Grossklauss DB; Alvarez M; Paixão FC; Andreis U; Crispim AG; de Castro AD; Evangelista RC; de Arruda Miranda JR
    Drug Dev Ind Pharm; 2014 Aug; 40(8):1123-31. PubMed ID: 23815300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of drug delivery systems in the gastrointestinal tract.
    Weitschies W; Wilson CG
    Int J Pharm; 2011 Sep; 417(1-2):216-26. PubMed ID: 21820499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a continuous dissolution/absorption system--a technical note.
    Gao Z
    AAPS PharmSciTech; 2012 Dec; 13(4):1287-92. PubMed ID: 22996672
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.
    Tubic-Grozdanis M; Bolger MB; Langguth P
    AAPS J; 2008; 10(1):213-26. PubMed ID: 18446522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patches for improving gastrointestinal absorption: an overview.
    Teutonico D; Ponchel G
    Drug Discov Today; 2011 Nov; 16(21-22):991-7. PubMed ID: 21683153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Materials to clinical devices: technologies for remotely triggered drug delivery.
    Timko BP; Kohane DS
    Clin Ther; 2012 Nov; 34(11):S25-35. PubMed ID: 23149010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key Considerations in Designing Oral Drug Delivery Systems for Dogs.
    Song Y; Peressin K; Wong PY; Page SW; Garg S
    J Pharm Sci; 2016 May; 105(5):1576-1585. PubMed ID: 27056627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotically controlled drug delivery system with associated drugs.
    Gupta BP; Thakur N; Jain NP; Banweer J; Jain S
    J Pharm Pharm Sci; 2010; 13(4):571-88. PubMed ID: 21486532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-mediated changes in the gastrointestinal tract.
    Merchant HA; Liu F; Orlu Gul M; Basit AW
    Int J Pharm; 2016 Oct; 512(2):382-395. PubMed ID: 27085646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms.
    Weitschies W; Kosch O; Mönnikes H; Trahms L
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1210-22. PubMed ID: 15935870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroretentive floating drug-delivery systems: a critical review.
    Kotreka UK; Adeyeye MC
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):47-99. PubMed ID: 21395515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced characterisation techniques.
    Perrie Y; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):1-2. PubMed ID: 21421035
    [No Abstract]   [Full Text] [Related]  

  • 18. Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers.
    Koziolek M; Grimm M; Schneider F; Jedamzik P; Sager M; Kühn JP; Siegmund W; Weitschies W
    Adv Drug Deliv Rev; 2016 Jun; 101():75-88. PubMed ID: 27037063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamic gastric environment and its impact on drug and formulation behaviour.
    Van Den Abeele J; Rubbens J; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2017 Jan; 96():207-231. PubMed ID: 27597144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.